RNA Editing Gordon Research Conference (GRC) Presentation … RNA Editing Gordon Research Conference (GRC) Oral presentation title: Development of RNA editing oligonucleotides technology to address liver … maart 23, 2023
RNA Leaders Europe Congress Presentation ProQR Presentation at RNA Leaders Europe Congress maart 16, 2023
Oligonucleotide and Precision Therapeutics (OPT) Congress Congress … Oral presentation title: Therapeutic potential of an RNA editing platform using Editing Oligonucleotides (EONs) … maart 14, 2023
ProQR Therapeutics Virtual R&D Event 2023 Webcast … event, the Company will showcase its proprietary Axiomer ® RNA-editing technology platform, announce initial pipeline … maart 29, 2023
Axiomer Investor Call Webcast … call and webcast to discuss the Company’s Axiomer RNA editing technology platform following the recently … september 09, 2021
Investor Call Webcast … 11-08-2022 - 13:00 ProQR to Focus Exclusively on Axiomer RNA-editing Technology and Partner Ophthalmology Programs - … augustus 11, 2022
Analyst and Investor Event Webcast … will highlight its proprietary Axiomer™ ADAR-mediated RNA editing platform, along with updates on its pipeline of … december 11, 2024
ProQR Analyst Event Webcast … Clinical Programs Aniz Girach, MD, Chief Medical Officer RNA Toolbox Gerard Platenburg, Chief Innovation Officer Q&A … advancements from its clinical-stage pipeline and Axiomer® RNA editing platform. 12:00 - 2:00 PM ET / 18:00 - 20:00 CET … november 18, 2021
American Society of Gene & Cell Therapy (ASGCT) Annual Meeting Congress … 8, 2024 poster presentations: P-705: “ Robust and Durable RNA Editing In Vivo with Axiomer™ Editing Oligonucleotides in … mei 07, 2024
ProQR Investor/Analyst Webcast: Lilly Partnership Expansion and Axiomer Overview Webcast … call and webcast to discuss the Company’s Axiomer RNA editing technology platform following the recently … december 22, 2022